GCS 100 IV - La Jolla Pharma
La Jolla: Corporate Presentation (La Jolla) - Jul 26, 2013 - "Encouraging Phase 1 Data"; "GCS-100 @ 30 (mg/m2) Significantly Reduces Galectin-3 Levels"; "Day 7 returns to above baseline level due to mobilization of tissue galectin-3" 
P1 data Renal Disease
http://ljpc.com/wp-content/uploads/2013/05/Corporate-Presentation_July2013.pdf
 
Jul 26, 2013
 
.
 
534fbf91-db58-4007-8315-22e29c0b03a6.jpg